Skip to content
MedsAcross

Alternatives

Alternatives to ENTYVIO Pen 108 mg/0.68 mL injection

1 other presentations of Vedolizumab 108 mg/0.68 mL injection

There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Vedolizumab), strength (108 mg/0.68 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
ENTYVIO Pen 108 mg/0.68 mL injectionThis pageSubcutaneousTakeda PharmaceuticalsUS FDA1 tray of 0.68 mLCold chainOn request—Available on request
Entyvio 108 mg/0.68 mL injectionSubcutaneousTakeda PharmaceuticalsUS FDA1 tray of 0.68 mLCold chainOn request—Available on request

This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to ENTYVIO Pen 108 mg/0.68 mL injection

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.